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Haemophilus parasuis, a member of the family Pasteurellaceae, is a common inhabitant of the upper respiratory tract
of healthy pigs and the etiological agent of Glässer’s disease. As other virulent Pasteurellaceae, H. parasuis can
prevent phagocytosis, but the bacterial factors involved in this virulence mechanism are not known. In order to
identify genes involved in phagocytosis resistance, we constructed a genomic library of the highly virulent
reference strain Nagasaki and clones were selected by increased survival after incubation with porcine alveolar
macrophages (PAM). Two clones containing two virulent-associated trimeric autotransporter (VtaA) genes, vtaA8
and vtaA9, respectively, were selected by this method. A reduction in the interaction of the two clones with the
macrophages was detected by flow cytometry. Monoclonal antibodies were produced and used to demonstrate
the presence of these proteins on the bacterial surface of the corresponding clone, and on the H. parasuis
phagocytosis-resistant strain PC4-6P. The effect of VtaA8 and VtaA9 in the trafficking of the bacteria through the
endocytic pathway was examined by fluorescence microscopy and a delay was detected in the localization of the
vtaA8 and vtaA9 clones in acidic compartments. These results are compatible with a partial inhibition of the routing
of the bacteria via the degradative phagosome. Finally, antibodies against a common epitope in VtaA8 and VtaA9
were opsonic and promoted phagocytosis of the phagocytosis-resistant strain PC4-6P by PAM. Taken together,
these results indicate that VtaA8 and VtaA9 are surface proteins that play a role in phagocytosis resistance of
H. parasuis.Introduction
Haemophilus parasuis is a member of the family Pasteur-
ellaceae and a common inhabitant of the upper respira-
tory tract of healthy pigs. It is also known as the
etiological agent of Glässer’s disease in swine, a systemic
disease characterized by fibrinous polyserosytis, which
causes high morbidity and mortality in piglets. H. para-
suis can also produce pneumonia and sudden death [1].
Glässer’s disease has gained considerable importance in
recent years and it is recognized as one of the main
causes of economic loss in the pig industry [2].
Little is known about the pathogenesis and the virulence
factors of H. parasuis. Some putative virulence factors
have been reported [3-8], including a family of trimeric
autotransporters, designated virulence-associated trimeric
autotansporters (VtaA) [9]. Trimeric autotransporters are
present in Gram-negative bacteria and they have been* Correspondence: virginia.aragon@cresa.uab.es
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distribution, and reproduction in any mediumwidely confirmed as virulence factors in other bacteria
[10,11].
Vahle et al. [12] determined the dynamics of infection
with H. parasuis after intranasal inoculation with a sys-
temic isolate, showing that H. parasuis has to survive
host pulmonary defences in order to produce systemic
disease. In the lung, the first line of defence is composed
of alveolar macrophages, whose main role is the elimin-
ation of airborne pathogens and other environmental
particles [13,14]. The phagocytosed particles are subse-
quently destroyed as they progress along the degradative
endocytic pathway, culminating in the formation of the
mature phagolysosome. [15]. Like other virulent Pasteur-
ellaceae [16-19], H. parasuis has evolved mechanisms to
prevent phagocytosis as part of its pathogenic profile, as
demonstrated in a previous study [20]. These mechan-
isms allow microorganisms to avoid destruction via the
degradative endocytic pathway and in some cases pre-
vent phagocytosis [21].
In order to identify the genes involved in this virulence
mechanism of H. parasuis, we constructed a genomicCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and clones from the library were selected by incubation
with porcine alveolar macrophages (PAM). Two vtaA,
vtaA8 and vtaA9 were identified and their role in phago-
cytosis resistance was explored, demonstrating for the
first time the involvement of these two proteins in resist-
ance to phagocytosis in H. parasuis.Materials and methods
Bacterial strains and plasmids
Bacterial strains and plasmids used in this study are
listed in Table 1. Escherichia coli EPI300 was used as
the host for recombinant plasmids and was grown on
Luria-Bertani (LB) agar or in LB broth, supplemented
with 100 μg/mL ampicillin, 12.5 μg/mL chlorampheni-
col (pCC1FOS) or 30 μg/mL chloramphenicol
(pACYC184), as appropriate. H. parasuis strains were
grown on chocolate agar.Genomic library production
A genomic library derived from the H. parasuis virulent
strain Nagasaki was produced with the CopyControlTM
Fosmid Library Production kit (Epicentre Biotechnolo-
gies, Madison, USA) with pCC1FOS™, according to the
manufacturer’s instructions. Genomic DNA from theTable 1 Bacterial strains and plasmids used in this study.
Description Reference
STRAINS
H. parasuis
Nagasaki virulent reference strain, serovar 5 [22]
PC4-6P virulent field strain,serovar 12 [20]
SW114 non-virulent reference strain, serovar 3 [22]
F9 non-virulent field strain, serovar 6 [20]
E. coli
EPI300 Phage T1-resistant Epicentre
Biotechnologies
PLASMIDS
pCC1FOS inducible copy, CmR Epicentre
Biotechnologies
pACYC184 low copy, CmR, TetR ATCC number
37033
pEGFP gfp, AmR Clontech
pCC1FOS-8 pCC1FOS with a 47,195 bp
insert, including vtaA8
this paper
pCC1FOS-9 pCC1FOS with a 38,659 bp insert,
including vtaA9
this paper
pMCH-vtaA8 vtaA8 cloned in the BamHI
site of pACYC184
this paper
pMCH-vtaA9 vtaA9 cloned in the BamHI
site of pACYC184
this paper
Cm: Chloramphenicol.
Tet: Tetracycline.
Am: Ampicillin.Nagasaki strain was purified with a Nucleospin blood kit
(Macherey-Nagel, Düren, Germany) and fragments of
approximately 40 kb were used for library construction.
The genomic library consisted of 300 fosmid clones, to
ensure a complete library with a 99% probability.Sequencing, PCR and cloning
To identify the genomic sequence included in selected
fosmids, these clones were induced to high copy num-
ber and pCC1/pEpiFOS forward and reverse primers
(Epicentre Biotechnologies) were used in sequencing
reactions using a BigDye Terminator v.3.1 kit and
an ABI 3100 DNA sequencer (Applied Biosystems,
Carlsbad, USA). The complete sequence included in
each fosmid was deduced by comparison with the
Nagasaki genome sequence [9].
In addition, two genes of interest, vtaA8 and vtaA9,
were PCR-amplified from the corresponding fosmid
clones with primers GCGCGGATCCTCTTAGTTTTG
TGTAACTCTT and GCGCGGATCCTTCTAATTTATA
GGTGCTAGATTAC (BamHI site in primer sequence is
underlined) and AccuprimeTM Taq DNA polymerase
high fidelity (Invitrogen, Madrid, Spain). The amplicons
were then digested with BamHI and cloned into the
BamHI site of pACYC184 to yield pMCH-vtaA8 and
pMCH-vtaA9 (Table 1) for further study.Phagocytosis assay
Phagocytosis assays were performed as described before
[20]. Briefly, porcine alveolar macrophages (PAM) were
seeded in 6-well plates at a concentration of 5 × 105 cells
in 3 mL per well of Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS) and 1% L-glutamine, complete DMEM (CDMEM).
Plates were incubated at 37°C with 5% CO2, and after at-
tachment of the cells to the wells (for a minimum of 1 h
up to overnight incubation), the wells were inoculated
with bacteria at a multiplicity of infection (MOI) of 200.
Selected E. coli transformants were also transformed
with pEGFP (plasmid carrying the green fluorescent pro-
tein [GFP] gene) for this assay, and fluorescein isothio-
cyanate (FITC)-labeled H. parasuis strains were used as
controls. After incubation at 37°C for different times,
wells were washed to eliminate unbound bacteria and
PAM with associated bacteria were detected by flow
cytometry in an EPICS XL-MCLTM flow cytometer
(Beckman Coulter, Madrid, Spain). Assays were per-
formed in duplicate and were repeated using PAM from
different animals.
In some experiments, pMCH-vtaA8 and pMCH-vtaA9
were incubated in the same well with PAM to examine
their interaction.
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For survival studies, an MOI of 1 was used in the phago-
cytosis assay. After 1 h, 2 h, 3 h and 5 h PAM were lysed
with 0.1% saponin and pippeting. Live bacteria in the
wells were quantified by dilution and plating. Duplicate
wells were used and the assay was repeated four times.
Monoclonal antibody production
Monoclonal antibodies (mAb) were produced against
VtaA8 and VtaA9 by immunizing BALB/c mice with
their recombinant passenger domains. All procedures in-
volving animals were performed in accordance with the
regulations required by the Ethics Commission in Ani-
mal Experimentation of the Generalitat de Catalunya
(Approved Protocol Number 5767). Passenger domains
of VtaA8 and 9 were produced and purified as recom-
binant proteins (rVtaA8 and rVtaA9) following the
protocol of Olvera et al. [23].
Mice were subcutaneously immunized with 50 μg of
purified rVtaA8 or rVtaA9 with complete Freund’s adju-
vant, followed by a second dose of protein with incom-
plete Freund’s adjuvant 2 weeks later. Two weeks after
the second immunization and one day before the sacri-
fice, animals were boosted with 10 μg of protein in saline
solution. Hybridomas were produced by fusion of
lymphoid cells with X63AG8 myeloma cells following
standard methods [24]. Undiluted supernatants from
growing hybridomas were screened by indirect ELISA,
using 100 ng/well of rVtaA8 or rVtaA9. Positive hybri-
domas were sub-cloned and further characterized by
western blotting after purification using a protein A-
Sepharose column (GE Healthcare, Barcelona, Spain).
Western blotting was performed following standard
methods in an SDS-PAGE system with 10% polyacryl-
amide gels and nitrocellulose membranes [25].
Isotyping of selected mAb (69C6, 80H8 and 95F4) was
performed with a mouse monoclonal antibody isotyping
test kit (AbD Serotec, Kidlington, UK) according to the
manufacturer’s instructions.
Bacterial VtaA8 and VtaA9 localization
MAb were used to detect VtaA8 and VtaA9 on the bac-
terial surface by flow cytometry. EPI300 (pACYC184),
(pMCH-vtaA8) and (pMCH-vtaA9) were resuspended to
an OD660 of 1. Monoclonal antibodies were used at 50
ng/μL, and incubated with the bacterial suspensions
overnight on ice. After 3 washes with 1% bovine serum
albumin (BSA) in phosphate buffered saline (PBS) to
eliminate unbound antibodies, samples were incubated
with a FITC-conjugated goat anti-mouse IgG (Jackson
ImmunoResearch Europe Ltd, Newmarket, UK). After 2
washes to eliminate unbound conjugate, bacterial sus-
pensions were analysed by flow cytometry in an EPICS
XL-MCLTM flow cytometer. H. parasuis PC4-6P wasalso processed in the same manner, with strain F9 as the
negative control.
Opsonophagocytosis
The opsonic capacity of antibodies against VtaA8 and
VtaA9 was tested in an opsonophagocytosis assay.
Phagocytosis-resistant strain PC4-6P was used in these
assays and was opsonized with monoclonal antibodies. A
hyperimmune rabbit serum produced against the Naga-
saki strain was used as a positive control. Opsonization
of PC4-6P was performed overnight on ice using 200
ng/μL of each monoclonal antibody. After washes to
eliminate unbound antibodies, bacterial suspensions
were labeled with FITC and used in phagocytosis assays
in triplicate wells as described above. F9 and SW114
were also included as control of phagocytosis.
Immunofluorescence
Bacterial intracellular localization was determined by im-
munofluorescence following a previously published
protocol with modifications [26]. PAM were seeded on
glass coverslips in 6-well plates with CDMEM and
phagocytosis assays were performed as described above.
Early endosomes were detected with antibodies against
early endosome antigen 1 (EEA1), purchased from Santa
Cruz Biotechnologies (Santa Cruz, USA) and acidic
compartments were detected with Lysotracker Red
DND-99 (Invitrogen). H. parasuis strains PC4-6P (viru-
lent) and F9 (non-virulent) were used to examine intra-
cellular localization after 1 h of incubation at 37°C with
PAM. For E. coli clones (pACYC184, pMCH-vtaA8 and
pMCH-vtaA9; all with pEGFP), 1 h of pre-incubation on
ice was performed to allow bacterial attachment to
macrophages. Then, plates were incubated for 30 min
and 1 h at 37°C. For the detection of acidic compart-
ments, Lysotracker was added to the wells at a 1:2000
dilution at the same time as the bacterial inoculum.
After the corresponding incubation (30 min or 1 h), cov-
erslips were washed with PBS and immediately fixed
with 4% paraformaldehyde (PFA) in PBS for 15 min at
room temperature (RT). After fixing, samples were per-
meabilized with 0.5% Triton X-100 for 15 min at RT.
Samples were then blocked with donkey serum (Jackson
ImmunoResearch) for 1 h at RT and then incubated at
4°C overnight with goat anti-EEA1 diluted 1:20 in 3%
BSA-PBS. H. parasuis strains were detected inside the
PAM with a 1:100 dilution of a mix of hyperimmune
rabbit sera produced against Nagasaki and SW114
strains. After three washes with PBS, coverslips were
incubated with Cy3-conjugated donkey anti-goat IgG
(H+L) or FITC-conjugated anti-rabbit IgG (whole mol-
ecule) for 1 h in 3% BSA-PBS at RT. E. coli clones were
detected by GFP expression. Finally, nuclei were coun-
terstained with 4',6-diamidino-2-phenylindole (DAPI) at
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Fluorescent images were viewed on a Nikon eclipse 90i
epifluorescence microscope equipped with a DXM
1200F camera (Nikon Corporation, Japan). Image stacks
were captured using OLYMPUS FluoView FV1000 con-
focal microscope (×60/NA 1.35 objective). Z stack
images were acquired at intervals of 1 μm. Images were
processed using FV10-ASW 1.7 Viewer software from
Olympus and Image J v1.46d software [27].
To determine the percentage of bacteria that co-
localized with each marker, approximately 100 cells were
analyzed in each experiment. The results were calculated
from 2 independent experiments as the percentage of
cells with bacteria co-localizing with each marker within
the group of infected PAM and statistical differences
were determined by a Chi-squared test using a signifi-
cance threshold of p< 0.05.
Apoptosis assay
Apoptosis was detected by immunofluorescence assay
using caspase-3 antibodies (Asp175; Cell Signaling tech-
nology, Danvers, USA). Apoptotic cells reacting with the
antibody were observed after 1 h at RT incubation with
a DyLight 549 goat anti-rabbit IgG (H+L) (Jackson
ImmunoResearch) under a fluorescence microscope.
Results
Selection of phagocytosis-resistant clones
In order to identify genes involved in phagocytosis re-
sistance, a genomic library derived from the Nagasaki
strain was screened by sequential incubations with PAM.
Several clones were selected based on increased survival
as compared to E. coli EPI300 (pCC1FOS).
Twenty clones were partially sequenced and their
complete sequences were deduced by comparison with
the Nagasaki genomic sequence. Two of those fosmid
clones (pCC1FOS-8 and pCC1FOS-9) contained genes
encoding 2 different trimeric autotransporter genes (vtaA8
and vtaA9, respectively) and were selected for further
study (Table 1). Insert size was 47,195 bp in pCC1FOS-8
(corresponding to nucleotides 912,650 to 959,845 of the
SH0165 genome; accession number NC_011852) and
38,659 bp in pCC1FOS-9 (corresponding to nucleotides
676,395 to 700,323 of the SH0165 genome).
E. coli EPI300 (pCC1FOS-8) and EPI300 (pCC1FOS-9)
were transformed with pEGFP and analysed in phagocyt-
osis assays by flow cytometry. Both clones showed a
reduced interaction with PAM as compared to E.coli
EPI300 (pCC1FOS pEGFP) (not shown). A randomly
selected fosmid clone was used as the control and it
showed the same interaction with PAM as the control
strain carrying the empty vector (data not shown). To
determine the role of vtaA8 and vtaA9, the genes were
PCR-amplified and cloned into pACYC184 to givepMCH-vtaA8 and pMCH-vtaA9, and were introduced
into E. coli EPI300 together with pEGFP. Compared to
EPI300 (pACYC184 pEGFP), EPI300 (pMCH-vtaA8
pEGFP) and EPI300 (pMCH-vtaA9 pEGFP) showed a
reduced interaction with PAM in phagocytosis assays
(Figure 1). After 1 h of incubation at 37°C, 29% of PAM
incubated with EPI300 (pACYC184 pEGFP) had asso-
ciated bacteria (gate B of control panel) and at 3 h almost
all bacteria were degraded, as shown by a reduction in
fluorescence intensity (xmean of 40, gate C of control
panel). In contrast, PAM incubated 1 h with EPI300
(pMCH-vtaA8 pEGFP) or EPI300 (pMCH-vtaA9 pEGFP)
showed a lower percentage of macrophages with fluores-
cent bacteria than the control with the empty vector
(around 10%; Figure 1, gate B of panels vtaA8 and
vtaA9). After 3 h of incubation, a high percentage of
PAM had associated EPI300 (pMCH-vtaA8 pEGFP) and
EPI300 (pMCH-vtaA9 pEGFP) (Figure 1, gate C of panels
vtaA8 and vtaA9). However, the mean fluorescence in-
tensity of these macrophages was higher than the macro-
phages with control bacteria (gate C xmean of 50 and
95.5, for vtaA8 and vtaA9, respectively), indicating that
those clones required longer periods of incubation before
finally being phagocyted and for complete bacterial de-
struction. Simultaneous incubation of both the clones
had no synergic effect in phagocytosis.
As the control, growth curves of EPI300 (pACYC184),
(pMCH-vtaA8) and (pMCH-vtaA9) were evaluated and
no differences were observed (data not shown), indicat-
ing that differences in phagocytosis susceptibility were
not due to differences in growth.
Attachment of the clones was also examined by in-
cubating the clones with PAM on ice. EPI300 (pMCH-
vtaA8 pEGFP) and EPI300 (pMCH-vtaA9 pEGFP)
showed no reduction in adhesion to the surface of the
PAM, as compared to EPI300 (pACYC184 pEGFP)
(Figure 2), indicating that the differences observed in
phagocytosis assays were not due to differences in ad-
hesion ability. In fact, a slight increase in attachment
was observed in EPI300 (pMCH-vtaA8 pEGFP).Bacterial survival in the presence of PAM
Survival kinetics of EPI300 (pMCH-vtaA8) and EPI300
(pMCH-vtaA9) was examined after 1 h, 2 h, 3 h and 5 h
of incubation with PAM. Although EPI300 (pMCH-
vtaA8) showed better survival after 1 h of incubation
and EPI300 (pMCH-vtaA9) after 2 h or longer incuba-
tion times, no significant differences with EPI300
(pACYC184) were observed. This may indicate that
there is a small difference in survival (not detected by
this test) that can be discerned only after successive
passes with PAM (as the selection of the clones was
performed).
FL1 (GFP)
1 h 3 h
Control
vtaA8
vtaA9
81.1% 10.3%
16.4%
80.5%
9.1%72.9%
22.1%
72.7%
72.8%29.1%
21.9%
60.1%
18 22
23 32
25 27
100           101 102          103100           101 102          103
A
B
A
C
Figure 1 VtaA8 and VtaA9 reduced the bacterial interaction with porcine alveolar macrophages (PAM). E. coli EPI300 clones pMCH-vtaA8
(vtaA8) and pMCH-vtaA9 (vtaA9), also carrying pEGFP, were incubated for 1 h or 3 h with PAM and the interaction with the macrophages was
analysed by flow cytometry. Results show the macrophages with fluorescent bacteria given by GFP and measured in FL1 (gates B and C, for 1 h
and 3 h, respectively). E. coli with the empty vector pACYC184 and pEGFP was used as a control. Percentages of macrophages in gates A, B and
C are included in the panels.
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Preliminary observations of different auto-agglutination
patterns were detected in EPI300 (pMCH-vtaA8) and
EPI300 (pMCH-vtaA9) with respect to the control,
pointing out differences on the surface of the clones. To
confirm the surface expression of VtaA8 and VtaA9 in
the clones, mAb were produced against the proteins and
were used in flow cytometry. MAb 69C6, which demon-
strated by ELISA and western blot reaction against both
VtaA8 and VtaA9 (not shown), also showed a positive
reaction with the clones EPI300 (pMCH-vtaA8) and
EPI300 (pMCH-vtaA9) in flow cytometry (Figure 3).
These results indicate that the proteins VtaA8 and
VtaA9 are effectively expressed by the corresponding
clone. In addition, mAb 69C6 also detected an epitope
on the surface of strain PC4-6P, which was not detected
in nasal strain F9 (Figure 4).Intracellular localization of phagocyted bacteria
To explore the role of VtaA8 and VtaA9 in phagocytosis
resistance, we examined the bacterial trafficking with-
in the endosomal network. Initially, experiments with
the phagocytosis-resistant strain PC4-6P and the
phagocytosis-susceptible strain F9 of H. parasuis were
performed. As previously described [20], PC4-6P, which is
a systemic strain, showed a lower level of association with
the macrophages than the nasal strain F9. After incuba-
tion of the H. parasuis strains for 1 h with PAM, we la-
belled EEA1 (as an early endosome marker) and the
bacteria. Bacterial co-localization with this marker was
quantified as the percentage of infected macrophages with
co-localizing bacteria-marker. No differences were
detected in the co-localization of H. parasuis F9 and PC4-
6P with EEA1, which was observed in a low percentage of
infected macrophages (Figure 5 and Additional file 1:
46
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Figure 2 VtaA8 and VtaA9 did not reduce bacterial attachment
to PAM. Flow cytometry of PAM after 1 h incubation at 0°C with
EPI300 (pACYC184 pEGFP) (gray histogram), EPI300 (pMCH-vtaA8
pEGFP) (solid line) and EPI300 (pMCH-vtaA9 pEGFP) (dotted line).
FL1 (FITC)
100                      101 102                     103
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Figure 4 Detection of VtaA8 and VtaA9 on the surface of
H. parasuis. Phagocytosis-resistant strain PC4-6P was incubated
with monoclonal antibody 69C6 directed against VtaA8 and VtaA9.
Reaction was detected with a FITC-conjugated anti-mouse antibody
and analyzed by flow cytometry (bold line). Phagocytosis-
susceptible strain F9 was included as a negative control (shown in
gray). As an additional control, PC4-6P incubated only with the
secondary antibody is also shown (fine line).
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the maturation process, LysoTracker Red DND-99 was
used to monitor the maturation of the endocytic compart-
ment. With this marker, clear differences were observed in
co-localization of strains PC4-6P and F9 (p= 0.001). Strain
F9 was found in acidic compartments (co-localizing with
LysoTracker Red DND-99) approximately two times more
frequently than strain PC4-6P (Figure 5 and Additional
file 1: Figure S1). These results suggest that F9 bacteria100                                 101 102                                 103
FL1 (FITC)
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Figure 3 Detection of VtaA8 and VtaA9 on the surface of the
corresponding clone. E. coli EPI300 (pMCH-vtaA8) (bold line) and
EPI300 (pMCH-vtaA9) (fine line) were incubated with monoclonal
antibody 69C6 directed against VtaA8 and VtaA9. Reaction was then
detected with an anti-mouse antibody conjugated with FITC and
analyzed by flow cytometry. E. coli EPI300 (pACYC184) served as a
negative control (shown in gray).are properly internalized and degraded in acidic compart-
ments while phagocytosis of the few internalized PC4-6P
bacteria is postponed.
In order to examine whether VtaA8 and VtaA9 play a
role in altering the endocytosis route, co-location of
EPI300 (pMCH-vtaA8 pEGFP) and (pMCH-vtaA9 pEGFP)
with EEA1 and lysotracker was studied. After 1 h of incu-
bation on ice to synchronize attachment, subsequent time
points (30 min and 1 h) were analyzed at 37 °C. After 30
min of phagocytosis, a small percentage of macrophages
showed the control EPI300 (pACYC184 pEGFP) in EEA1-
positive compartments, while the majority had the E. coli
control in lysotracker-positive compartments, indicating its
main localization in acidic compartments (Figure 6, Add-
itional file 2: Figure S2A and Figure S2B). In contrast,
EPI300 (pMCH-vtaA8 pEGFP) and EPI 300 (pMCH-vtaA9
pEGFP) were detected in EEA1-positive compartments
more frequently than the control (20% and 33% respect-
ively vs. 14%) at 30 min, but these differences were not
statistically significant (p> 0.05). In addition, EPI300
(pMCH-vtaA8 pEGFP) and EPI300 (pMCH-vtaA9 pEGFP)
showed a reduced co-localization with lysotracker after
30 min of phagocytosis as compared to the control (11%
and 21% vs. 70%, p< 0.001; Figure 6, Additional file 2:
Figure S2A and Figure S2B).
After 1 h of phagocytosis, the percentage of macro-
phages with EPI300 (pACYC184 pGFP) in EEA1-
Figure 5 Intracellular localization of two different H. parasuis strains: F9 (non-virulent strain) and PC4-6P (virulent strain) within the
endosomal network of PAM. After 1 h of incubation with PAM, bacteria were labelled with a rabbit anti-H. parasuis hyperimmune serum
followed by an anti-rabbit-FITC (green signal) and nuclei were counterstained with DAPI (blue signal). The upper panels show the co-localization
between F9 (left panel) or PC4-6P (right panel) and the early endosomal marker EEA1. EEA1 was stained with goat anti-EEA1 and anti-goat-Cy3
(red) antibodies. The lower panels show the co-localization between F9 (arrow in the left panel) or PC4-6P (detail in the inset in the right panel)
and the acidic lysosomes stained with LysoTracker Red DND-99 (red signal). Percentages of co-localization are indicated in each panel. Scale bars,
5 μm. The images showing the individual fluorescences are presented in Additional file 1: Figure S1.
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(although not statistically significative), while the co-
localization with the lysotracker showed a reduction
(p= 0.02; Figure 6, Additional file 2: Figure S2A and
Figure S2B). These results are compatible with a second
wave of phagocytosis of these bacteria. Co-localization of
EPI300 (pMCH-vtaA8 pEGFP) with EEA1 and lyso-
tracker was found in a higher percentage of macro-
phages after 1 h than at 30 min, indicating a progressive
trafficking within the endocytic pathway. This progres-
sion was more clearly observed in EPI300 (pMCH-vtaA9
pEGFP) infected macrophages, which showed a high
percentage of co-localization with lysotracker after 1 h
of phagocytosis (p= 0.004; Figure 6, Additional file 2:
Figure S2A and Figure S2B).
Taken together, these results support a delay in the
processing by macrophages of the E. coli clones carrying
the VtaA8 or VtaA9 genes with respect to the control
carrying the empty vector.
No apoptosis, as determined by caspase-3 detection,
was observed after incubation of PAM with H. parasuis
strains PC4-6P or F9, or after incubation with the vtaA8
and vtaA9 clones (not shown).
Opsonophagocitosis
The opsonic capacity of mAb 69C6 (isotype IgG2b) and
95F4 (selected for its reaction against VtaA8 and VtaA9in ELISA, but not in western blotting; IgM) was evalu-
ated. After incubation of the phagocytosis-resistant
strain PC4-6P with the antibodies to allow for
opsonization, phagocytosis was examined by flow cyto-
metry. Opsonization of the resistant strain PC4-6P with
mAb 69C6 or 95F4 yielded the strain susceptible to the
phagocytosis by PAM, to levels similar to the nasal
strains included in the assay (Figure 7). MAb 80H8 (iso-
type IgG2b) showed no opsonic capacity in this assay
(Figure 7).
Discussion
In this study, we provide evidence showing that two tri-
meric autotransporters of H. parasuis, VtaA8 and VtaA9,
are surface-exposed proteins that are involved in resist-
ance to phagocytosis. Since the production of mutants
in H. parasuis is hindered by low and strain-dependent
transformation efficiency [7,28], we decided to use the
strategy of studying the function of specific genes in the
heterologous host, E. coli. Thus, the expression of the in-
dividual proteins in E. coli, although not enough to pre-
vent phagocytosis, produced a delay in the phagocytosis
process. This strategy allowed us also to circumvent the
problem derived from the existence of several vtaA in H.
parasuis [9], which suggests a functional redundancy.
Trimeric autotransporters mediate virulence mechan-
isms in other Gram-negative bacteria [29-31] and their
Figure 6 Intracellular localization of the E. coli clones carrying vtaA8 and vtaA9 from H. parasuis within the endosomal network of PAM
at different times post-infection (30 min and 1 h). E. coli (pACYC184 pEGFP) (Control, first column) and the clones with vtaA8 (pMCH-vtaA8
pEGFP; vtaA8, second column) or vtaA9 (pMCH-vtaA9 pEGFP; vtaA9, third column) were expressing GFP (green signal). Nuclei were
counterstained with DAPI (blue signal). Upper panels show the co-localization (arrows) between control, vtaA8 or vtaA9 and the early endosomal
marker EEA1 (red signal). Lower panels show the co-localization (arrows) between the control, vtaA8 or vtaA9 and the acidic lysosomes stained
with LysoTracker Red DND-99 (red signal). Percentages of co-localization are indicated in each panel. Scale bars, 5 μm. Individual images for each
fluorescence are presented in the Additional file 2: Figure S2A and Figure S2B.
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ously demonstrated in Neisseria meningitiditis, a Gram-
negative bacterium capable of producing systemic disease
[32].
Recently, VtaA genes of group 1 (in which vtaA8 and
vtaA9 are included) have been found widely represented
in virulent strains of H. parasuis [9,33]. When expressed
in E.coli, VtaA8 and VtaA9 promoted resistance to
phagocytosis by PAM in an attachment-independent
way. Both, flow cytometry and fluorescent microscopy
support the role of these proteins in phagocytosis, but
the proteins were unable to block the process and the
bacteria eventually proceeded into the endocytic net-
work. Our results indicate that VtaA8 and VtaA9 alone
are not sufficient to avoid phagocytosis, and other fac-
tors may be involved, such as capsules, as previously
suggested [20].The N-terminal domain of trimeric autotransporters is
exposed to the external media and to the host immune
response [11]. The exposure of VtaA8 and VtaA9 on the
bacterial surface was demonstrated with monoclonal
antibodies. The presence of these proteins on the surface
of virulent strain PC4-6P, while absent on the non-
virulent strain F9, support the association of these tri-
meric autotransporters with virulence. In addition, the
antibodies produced against the VtaA8 and VtaA9 of the
Nagassaki strain were able to recognize the heterologous
virulent strain PC4-6P. Although a mixture of VtaA was
not able to fully protect against a severe H. parasuis
challenge [34], this cross-reactivity supports the poten-
tial of these proteins as candidates in vaccine formula-
tions against H. parasuis. VtaA8 and VtaA9 probably are
redundant proteins affecting the PAM through the same
mechanism, since co-incubation with both proteins
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Figure 7 Opsonic capacity of monoclonal antibodies anti-Vta8
and VtaA9 as determined in opsophagocytosis assay.
Phagocytosis-resistant strain PC4-6P (gray bars) was incubated with
monoclonal antibodies 69C6, 95F4 and 80H8, against VtaA8 and
VtaA9, to allow opsonization of the bacteria. The opsonic capacity of
these antibodies was then evaluated in an opsonophagocytosis
assay with porcine alveolar macrophages (PAM). Opsonization with a
rabbit anti-H. parasuis serum was included as a positive control. Also,
two phagocytosis-susceptible strains, SW114 and F9 (black bars),
were included in the assay. MO indicates non-infected macrophages
(white bar). The results show the mean of the percentage of PAM
with associated bacteria from triplicate wells, and the error bars are
the standard deviation. For strain SW114 the error bar is too small to
be seen. Significant differences were detected between the
phagocytosis after PC4-6P opsonization with 69C6, 95F4 and rabbit
anti-H. parasuis compared to the non-opsonized PC4-6P (Student
t-test, p< 0.001). Monoclonal 80H8 demonstrated no opsonic
capacity.
Costa-Hurtado et al. Veterinary Research 2012, 43:57 Page 9 of 10
http://www.veterinaryresearch.org/content/43/1/57(both clones) did not synergistically increase the effect
against bacterial phagocytosis. Directing the immune re-
sponse to common epitopes from both proteins can con-
stitute a rational to improve the probability of vaccine
success. Nevertheless, the choice of the adjuvant is also
important for the induction of the right antibody sub-
class, since not all the IgG isotypes have the same cap-
acity to promote opsonophagocytosis [35,36].
In conclusion, VtaA8 and VtaA9 are surface exposed
proteins that play a role in phagocytosis resistance in
virulent strains of H. parasuis. VtaA8 and VtaA9 share
epitopes, which are also present on the surface of heter-
ologous virulent strains. These properties make these
proteins promising vaccine candidates against Glässer’s
disease.Additional files
Additional file 1: Figure S1. Intracellular co-localization of two
different H. parasuis strains within the endosomal network of PAM.
Nucleus counterstained with DAPI is shown in blue (first panel); bacteria
(F9 or PC4-6P) labelled with FITC are visualized in green (second panel);detection of early endosomal marker (EEA1) or acidic lysosomes
(Lysotracker) is shown in red (third panel); merged images are shown in
the last panel. Detail of the co-localization between PC4-6P and
Lysotracker is shown in the inset. Scale bars, 5 μm.
Additional file 2: Figure S2. A. Intracellular co-localization of
EPI300-pACYC184 pEGFP (Control), EPI300-pMCH-vtaA8 pEGFP
(vtaA8) and EPI300-pMCH-vtaA9pEGFP (vtaA9) bacteria with early
endosomal antigen 1 (EEA1) at different times post-infection (30
min and 1 h). Nucleus counterstained with DAPI is shown in blue (first
panel); bacteria (Control, vtaA8 and vtaA9) expressing GFP are visualized
in green (second panel); detection of EEA1 is shown in red (third panel);
merged images are shown in the last panel. Scale bars, 5 μm. B.
Intracellular localization of EPI300-pACYC184 pEGFP (Control), EPI300-
pMCH-vtaA8 pEGFP (vtaA8) and EPI300-pMCH-vtaA9pEGFP (vtaA9)
bacteria in acidic compartments at different times post-infection (30 min
and 1 h). Nucleus counterstained with DAPI is shown in blue (first panel);
bacteria (Control, vtaA8 and vtaA9) expressing GFP are visualized in green
(second panel); detection of acidic lysosomes (as detected with
Lysotracker) is shown in red (third panel); merged images are shown in
the last panel. Scale bars, 5 μm.
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